合肥立方制药股份有限公司申请III类会议

Company Overview - Hefei Lifang Pharmaceutical Co., Ltd. was established in 2002 and is located in Hefei City, primarily engaged in the pharmaceutical manufacturing industry [1] - The company has a registered capital of 1,901.82182 million RMB and a paid-in capital of 660 million RMB [1] Investment and Intellectual Property - Hefei Lifang Pharmaceutical has invested in 11 companies and participated in 5,000 bidding projects [1] - The company holds 89 trademark registrations and 88 patent registrations, along with 597 administrative licenses [1] Shareholder Information - Major shareholders include Ji Junqiu with 67.41% ownership, Deng Xiaojun with 10%, Gao Meihua with 5.34%, Li Xiaochang with 4.64%, and Cai Ying with 2% [1] Regulatory Communication - The company has applied for a "Type III meeting" with the CDE, which is currently in process, and such meetings are typically held within 75 days after the application [1]